<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>POLY HIST PD- pyrilamine maleate, chlorpheniramine maleate and phenylephrine hydrochloride liquid </strong><br>Poly Pharmaceuticals, Inc.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>POLY HIST PD</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>POLY HIST PD</h1>Antihistamine / Decongestant<br>Sugar Free / Alcohol Free / Dye Free<br><br><span class="Bold">DESCRIPTION: POLY HIST PD</span> is a sugar free, alcohol free, dye free, clear and colorless liquid with a <br>bubble gum odor and flavor. Each 5 mL (1 teaspoonful) contains:<br>Pyrilamine Maleate.................... 12.5 mg<br>Chlorpheniramine Maleate........... 2 mg<br>Phenylephrine HCl...................... 7.5 mg<br><br>Pyrilamine Maleate is an antihistamine that occurs as a white crystalline powder, usually having a <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">faint</span> odor. <br>It is very soluble in water, freely soluble in alcohol and chloroform, and slightly soluble in ether and benzene. <br>The chemical name is 1,2-Ethanediamine, N-[(4-methoxyphenyl)methyl]-N', N'dimethyl-N-2-pyridinyl-, (Z)-2-<br>butenedioate (1:1). Its structural formula is as follows:<br><br><div class="Figure"><img alt="Pyrilamine Maleate Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8728160d-6172-4f4e-b512-46f5d9bca733&amp;name=MM4.jpg"></div>
<br><br>Chlorpheniramine Maleate is an antihistaminic that occurs as a white, odorless crystalline powder. Its solutions <br>have a pH between 4 and 5. It is freely soluble in water, soluble in alcohol and chloroform, and slightly soluble <br>in ether and benzene. The chemical name is 2-Pyridinepropanamine, gamma-(4-chlorophenyl)-N,N-dimethyl-,<br>(Z)-2-butenedioate (1:1). Its structural formula is as follows:<br><div class="Figure"><img alt="Chlorpheniramine Maleate Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8728160d-6172-4f4e-b512-46f5d9bca733&amp;name=MM5.jpg"></div>
<br><br>Phenylephrine hydrochloride is an adrenergic that occurs as white or practically white, odorless crystals, having <br>a bitter taste. It is freely soluble in water and alcohol. It is affected by light. The chemical name is benzenemethanol, 3-hydroxy-alpha[(methylamino)methyl]-, hydrochloride (R)-. Its structural formula is as follows:<br><br><div class="Figure"><img alt="Phenylephrine Hydrochloride Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8728160d-6172-4f4e-b512-46f5d9bca733&amp;name=MM6.jpg"></div>
<br><span class="Bold"><br>Inactive ingredients:</span><br>Propylene glycol, sorbitol, glycerin, sodium saccharin, purified water, and bubble gum flavoring.<br>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY:</h1>
<span class="Bold">Pyrilamine Maleate: </span>Pyrilamine is an antihistamine belonging to the ethylenediamine class. Pyrilamine is a <br>highly effective H<span class="Sub">1</span> blocker which possesses local anesthetic activity. Pyrilamine antagonizes most of the <br>smooth muscle stimulating actions of histamine on the H<span class="Sub">1</span> receptors of the gastrointestinal tract, blood <br>vessels and bronchial muscle. It also antagonizes the actions of histamine that result in increased capillary <br>permeability and the formation of <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>. Pyrilamine has a duration of action of 4 to 6 hours in clinical studies.<br><br><span class="Bold">Chlorpheniramine Maleate:</span><br>Chlorpheniramine is an antihistamine belonging to the alkylamine class. It possesses anticholinergic and <br>sedative effects. Antihistamines appear to compete with histamine for H<span class="Sub">1</span> cell receptor sites on effector cells. <br>Chlorpheniramine Maleate does not prevent the release of histamine in response to injury, drugs or antigens. <br>Antihistamines effectively block most smooth muscle responses to histamine and acts as an antagonist of <br>the constrictor action of histamine on respiratory smooth muscle. Antihistamines counteract <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span> formation <br>and whealing in response to injury, antigens, or histamine-liberating drugs. Chlorpheniramine is readily absorbed <br>from the gastrointestinal tract and has a duration of 4 to 6 hours. Plasma half-life is approximately 22 hours. <br>Degradation products of chlorpheniramine's metabolic transformation by the liver are almost completely excreted <br>in 24 hours via the kidney. The alkylamines of which chlorpheniramine is the prototype, are among the most <br>potent H<span class="Sub">1</span> blockers. Although not so prone as others to cause <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, a significant proportion of patients <br>do experience this effect. CNS stimulation is more common in chlorpheniramine than in other groups of H<span class="Sub">1</span> blockers.<br><span class="Bold"><br>Phenylephrine Hydrochloride:</span><br>Phenylephrine is a potent postsynaptic alpha-receptor agonist with little effect on beta-receptors on the heart. <br>Phenylephrine has no effect on beta-adrenergic receptors of the bronchi or peripheral blood vessels. A direct <br>action at receptors accounts for the greater part of its effects; only a small part is due to its ability to release <br>norepinephrine. Therapeutic doses of phenylephrine mainly cause <span class="product-label-link" type="condition" conceptid="4137788" conceptname="Vascular constriction">vasoconstriction</span>. It increases resistance, <br>and to a lesser extent, decreases capacitance of blood vessels. Total peripheral resistance is increased, <br>resulting in increased systolic and diastolic blood pressure. Pulmonary arterial pressure is usually increased, <br>and renal blood flow is usually decreased. Following oral administration of phenylephrine, constriction of blood <br>vessels in the nasal mucosa relieves <span class="product-label-link" type="condition" conceptid="4195085" conceptname="Nasal congestion">nasal congestion</span> associated with <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> or <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">head colds</span>. Following oral <br>administration of phenylephrine, nasal decongestion may occur within 15 to 20 minutes and may persist for up <br>to 4 hours. Phenylephrine is irregularly absorbed from and readily metabolized in the gastrointestinal tract. <br>Phenylephrine is metabolized in the liver and intestine by monoamine oxidase. The metabolites and their route <br>and rate of excretion have not been identified. The pharmacologic action of phenylephrine is terminated at least <br>partially by uptake of the drug into the tissues.<br>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>Poly Hist PD is indicated for symptomatic relief of seasonal and <span class="product-label-link" type="condition" conceptid="40486433" conceptname="Perennial allergic rhinitis">perennial allergic rhinitis</span>, and <span class="product-label-link" type="condition" conceptid="4305500" conceptname="Vasomotor rhinitis">vasomotor rhinitis</span>.<br>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS:</h1><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span> to any of the ingredients. Patients known to be sensitive to other sympathomimetic amines <br>may exhibit cross sensitivity with this drug. Poly Hist PD is contraindicated in patients with severe <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, <br>severe <span class="product-label-link" type="condition" conceptid="317576" conceptname="Coronary arteriosclerosis">coronary artery disease</span> and patients on monoamine oxidase (MAO) inhibitor therapy. It is also <br>contraindicated in patients with <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span> or <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>. Antihistamines should not be administered to premature <br>or newborn infants or be used to treat lower respiratory tract symptoms or <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>.<br>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<h1>WARNINGS:</h1>
<span class="Bold">Pyrilamine Maleate and Chlorpheniramine Maleate:</span><br>Antihistamines should be used with considerable caution in patients with narrow angle <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, stenosing peptic <br><span class="product-label-link" type="condition" conceptid="4177703" conceptname="Ulcer">ulcer</span>, pyloroduodenal obstruction, symptomatic <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>, and <span class="product-label-link" type="condition" conceptid="433813" conceptname="Bladder neck obstruction">bladder neck obstruction</span>. In infants and <br>children especially, antihistamine overdosage may cause <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span> or <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>. As in adults, <br>antihistamines may diminish mental alertness in children. Chlorpheniramine Maleate has additional effects with <br>alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers) Patients should be warned about engaging <br>in activities requiring mental alertness, such as driving a car or operating appliances, machinery, etc.<br><br><span class="Bold">Phenylephrine Hydrochloride:</span><br>Sympathomimetic amines should be used with considerable caution in patients with <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, ischemic heart <br>disease, <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span> mellitus, <span class="product-label-link" type="condition" conceptid="4011560" conceptname="Raised intraocular pressure">increased intraocular pressure</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span> or <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>. <br>Sympathomimetics may produce central nervous system stimulation with <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span> or <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">cardiovascular collapse</span> <br>with accompanying <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>. DO NOT EXCEED RECOMMENDED DOSAGE. <span class="product-label-link" type="condition" conceptid="312938" conceptname="Hypertensive encephalopathy">Hypertensive crisis</span> could occur <br>with concurrent use of phenylephrine and monoamine oxidase (MAO) inhibitors, indomethacin or with beta blockers <br>and methyldopa. If a <span class="product-label-link" type="condition" conceptid="312938" conceptname="Hypertensive encephalopathy">hypertensive crisis</span> occurs, this drug should be discontinued immediately and therapy to lower <br>blood pressure should be instituted. <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span> should be managed by means of external cooling. The elderly <br>(approximately sixty years or older) are more likely to have adverse reactions to sympathomimetics. Overdosage of <br>sympathomimetics in this age group may cause <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, <span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>. Therefore, <br>safe use of a short-acting sympathomimetic should be demonstrated in the individual elderly patient before <br>considering the use of a sustained-release formulation. Discontinue use if adverse reaction(s) occur.<br>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>PRECAUTIONS:</h1>
<span class="Bold">General:</span><br>Antihistamines have an atropine-like action and therefore should be used with caution in patients with a <br>history of bronchial <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, <span class="product-label-link" type="condition" conceptid="4011560" conceptname="Raised intraocular pressure">increased intraocular pressure</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, cardiovascular disease and <br><span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>. Phenylephrine should be used with caution in patients with <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>,<br> cardiovascular disease and hyper-reactivity to ephedrine.<br>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-7"></a><p></p>
<h1>Information for Patients:</h1>Antihistamines may impair the mental and physical abilities required for the performance of potentially <br>hazardous tasks such as driving a vehicle or operating machinery. Patients should also be warned about <br>possible additive effects with alcohol and other central nervous system depressants (hypnotics, sedatives <br>and tranquilizers).<br>
</div>
<div class="Section" data-sectionCode="34074-5">
<a name="section-8"></a><p></p>
<h1>Drug/Laboratory Test Interactions:</h1>MAO inhibitors and tricyclic antidepressants may prolong and intensify the anticholinergic (drying) effects <br>of antihistamines. Beta-adrenergic blockers and MAO inhibitors may potentiate the pressor effect of <br>phenylephrine. Concurrent use of digitalis glycosides may increase the possibility of <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>. <br>Sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and <br>veratrum alkaloids. Concurrent use of tricyclic antidepressants may antagonize the effects of phenylephrine. <br>Concomitant use of antihistamines with alcohol, tricyclic antidepressants, barbiturates, and other CNS <br>depressants may have an additive effect.<br>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-9"></a><p></p>
<h1>Carcinogenesis, Mutagenesis, Impairment of Fertility:</h1>No long-term studies have been performed using Poly Hist PD to determine the long-term potential for <br>carcinogenesis, mutagenesis and impairment of fertility. In a four-year evaluation of phenylephrine, no <br>statistically significant associated between the drug and cancer was found.<br>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-10"></a><p></p>
<h1>Usage in Pregnancy:</h1>Pregnancy Category C: Moderate overexposure to phenylephrine has been found to contribute to <span class="product-label-link" type="condition" conceptid="4029540" conceptname="Congenital anomaly">birth defects</span> <br>in rabbits. Animal reproduction studies have not been conducted with the other ingredients in Poly Hist PD. <br>Poly Hist PD should be used during pregnancy only if the potential benefit justifies the possible risk to the fetus.<br>
</div>
<div class="Section" data-sectionCode="34079-4">
<a name="section-11"></a><p></p>
<h1>Labor and Delivery:</h1>Administration of phenylephrine to patients in late pregnancy or labor may cause fetal <span class="product-label-link" type="condition" conceptid="313601" conceptname="Oxygen supply absent">anoxia</span> or <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span> by <br>increasing contractility of the uterus and decreasing uterine blood flow.<br>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-12"></a><p></p>
<h1>Nursing Mothers:</h1>Due to the possible passage of antihistamines into breast milk, and because of the higher than usual risk for <br>infants from sympathomimetic amines and antihistamines, a decision should be made whether to discontinue <br>nursing or to discontinue the drug, taking into account the importance of both.<br>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-13"></a><p></p>
<h1>Pediatric Use:</h1>In infants and children especially, antihistamines in overdosage may cause <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucination</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span> or <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>. <br>As in adults, antihistamines may diminish mental alertness in children. In the young child particularly, they may <br>produce excitation.<br>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="section-14"></a><p></p>
<h1>Geriatric Use:</h1>The elderly (60 years and older) are more likely to experience adverse reactions from sympathomimetics and <br>antihistamines. Overdosage of sympathomimetics in this age group may cause <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, <br><span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>.<br>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-15"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<span class="Bold">Pyrilamine Maleate and Chlorpheniramine Maleate:</span><br>Chlorpheniramine maleate may cause slight to moderate <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> relatively infrequently. Other possible side effects <br>of antihistamines in general include: <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="4080559" conceptname="Baboon syndrome">drug rash</span>, <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic shock</span>, <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">photosensitivity</span>, excessive perspiration, <br><span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">chills</span>, dryness or the mouth, nose and throat; cardiovascular effects (<span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitation</span>, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <br><span class="product-label-link" type="condition" conceptid="316429" conceptname="Premature beats">extrasystoles</span>); hematological effects (<span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">hemolytic anemia</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>); CNS disturbances (sedation, <br><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, disturbed coordination, <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, excitation, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <br><span class="product-label-link" type="condition" conceptid="4142453" conceptname="Feeling high">euphoria</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span>, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, <span class="product-label-link" type="condition" conceptid="373474" conceptname="Diplopia">diplopia</span>, <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span>, <span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">tinnitus</span>, acute <span class="product-label-link" type="condition" conceptid="74052" conceptname="Labyrinthitis">labyrinthitis</span>, <span class="product-label-link" type="condition" conceptid="434889" conceptname="Dissociative disorder">hysteria</span>, <span class="product-label-link" type="condition" conceptid="444252" conceptname="Neuritis">neuritis</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>); <br>gastrointestinal effects (<span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">epigastric distress</span>, <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>); genitourinary effects <br>(<span class="product-label-link" type="condition" conceptid="4012368" conceptname="Increased frequency of urination">urinary frequency</span>, difficult urination, <span class="product-label-link" type="condition" conceptid="192450" conceptname="Retention of urine">urinary retention</span>, early menses) and respiratory effects (thickening of bronchial <br>secretions, tightness of the chest, <span class="product-label-link" type="condition" conceptid="314754" conceptname="Wheezing">wheezing</span> and <span class="product-label-link" type="condition" conceptid="4195085" conceptname="Nasal congestion">nasal stuffiness</span>).<br><br><span class="Bold">Phenylephrine Hydrochloride:</span><br>Hyper-reactive individuals may display ephedrine-like reactions such as <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitations</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <br>or <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>. Sympathomimetic amines have been associated with certain untoward reactions including <span class="product-label-link" type="condition" conceptid="4029621" conceptname="Fear">fear</span>, <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span>, <br><span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="4260836" conceptname="Blanching of skin">pallor</span>, respiratory difficulty, <span class="product-label-link" type="condition" conceptid="197684" conceptname="Dysuria">dysuria</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, <br><span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span>, and <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">cardiovascular collapse</span> with <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>. Phenylephrine may cause <span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">precordial pain</span>, <br><span class="product-label-link" type="condition" conceptid="4158346" conceptname="Respiratory distress">respiratory distress</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span>, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span> and <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>.<br>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-16"></a><p></p>
<h1>OVERDOSAGE:</h1>
<span class="Bold">Signs and symptoms:</span><br><span class="Bold">Pyrilamine Maleate and Chlorpheniramine Maleate:</span><br>Manifestations of antihistamine overdosage may vary from central nervous system <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> (sedation, <span class="product-label-link" type="condition" conceptid="321689" conceptname="Apnea">apnea</span>, <br><span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">cardiovascular collapse</span>) to stimulation (<span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremors</span> or <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>). Other signs and <br>symptoms may be <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">tinnitus</span>, <span class="product-label-link" type="condition" conceptid="437584" conceptname="Ataxia">ataxia</span>, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span> and <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>. Stimulation is particularly likely <br>in children, as are atropine-like signs and symptoms (<span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>, <span class="product-label-link" type="condition" conceptid="4011326" conceptname="Fixed dilatation of pupil">fixed dilated pupils</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="435371" conceptname="Hypothermia">hypothermia</span> and <br><span class="product-label-link" type="condition" conceptid="4302537" conceptname="Digestive system finding">gastrointestinal symptoms</span>.<br><span class="Bold"><br>Phenylephrine Hydrochloride:</span><br>May cause <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, <span class="product-label-link" type="condition" conceptid="376713" conceptname="Cerebral hemorrhage">cerebral hemorrhage</span> and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>. Ventricular <span class="product-label-link" type="condition" conceptid="316429" conceptname="Premature beats">premature beats</span> <br>and short paroxysms of <span class="product-label-link" type="condition" conceptid="4103295" conceptname="Ventricular tachycardia">ventricular tachycardia</span> may also occur. <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span> may be a symptom of <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>. <br><span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">Bradycardia</span> may also be seen early in phenylephrine overdosage through stimulation of baroreceptors. Excessive <br>CNS stimulation may result in <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">excitement</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span> and <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>. Other effects may include <span class="product-label-link" type="condition" conceptid="4260836" conceptname="Blanching of skin">pallor</span>, <br><span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">mydriasis</span>, <span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">hyperglycemia</span> and <span class="product-label-link" type="condition" conceptid="192450" conceptname="Retention of urine">urinary retention</span>. Severe overdosage may cause <span class="product-label-link" type="condition" conceptid="317376" conceptname="Tachypnea">tachypnea</span> or <span class="product-label-link" type="condition" conceptid="316814" conceptname="Hyperventilation">hyperpnea</span>, <br><span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucination</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span> or <span class="product-label-link" type="condition" conceptid="373995" conceptname="Delirium">delirium</span> but in some individuals, there may be <span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span> with <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span>, <br><span class="product-label-link" type="condition" conceptid="4229897" conceptname="Stupor">stupor</span> or <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span>. <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">Arrhythmias</span> (including <span class="product-label-link" type="condition" conceptid="437894" conceptname="Ventricular fibrillation">ventricular fibrillation</span>) may lead to <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> and <br><span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">circulatory collapse</span>. Severe <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span> can occur, probably due to compartmental shift rather than a depletion <br>of potassium.<br><br><span class="Bold">Treatment:</span><br>The patient should be induced to vomit even if <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span> has occurred spontaneously. Pharmacologic <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> by <br>the administration of ipecac is facilitated by physical activity and by the administration of eight to twelve ounces <br>of water. If <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span> does not occur within fifteen minutes, the dose of ipecac should be repeated.<br>Precautions against <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span> must be taken especially in infants and children. Following <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span>, any drug remaining <br>in the stomach may be absorbed by activated charcoal administered as a slurry with water. If <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> is unsuccessful <br>or contraindicated, gastric lavage should be performed. Isotonic and one-half isotonic saline are the lavage solution of <br>choice. Saline cathartics, such as milk of magnesia, draw water into the bowel by osmosis and therefore, may be <br>valuable for their action in rapid dilution of bowel content. After emergency treatment, the patient should continue to <br>be medically monitored. Treatment of the signs and symptoms of overdosage is symptomatic and supportive.<br>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-17"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>
<span class="Bold">Adults and Children 12 years of age and over:</span><br>1-2 teaspoonfuls every 4-6 hours.<br><span class="Bold">Children 6 to under 12 years of age:</span><br>1/2 teaspoonful every 4-6 hours.<br><span class="Bold">Not recommended for Children under 6 years of age.</span><br>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-18"></a><p></p>
<h1>HOW SUPPLIED:</h1>16 fluid ounce bottles, NDC 50991-405-16 and 20 mL bottles, NDC 50991-405-20.<br><br><span class="Bold">KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. <br>IN CASE OF ACCIDENTAL <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">OVERDOSE</span>, CONTACT A POISON</span><span class="Bold"> CONTROL <br>CENTER OR SEEK PROFESSIONAL ASSISTANCE IMMEDIATELY.</span>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="section-19"></a><p></p>
<h1>Storage:</h1>Store at controlled room temperature, 15<span class="Sup">o</span>-30<span class="Sup">o</span>C (59<span class="Sup">o</span>-86<span class="Sup">o</span>F).<br><br><span class="Bold">DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINER WITH A CHILD-RESISTANT <br>CLOSURE AS DESCRIBED IN THE USP/NF.</span><br><br><span class="Bold">CAUTION: FEDERAL LAW PROHIBITS DISPENSING WITHOUT A PRESCRIPTION.</span><br><br>Manufactured by:<br>Great Southern Laboratories,<br>Houston, TX 77099<br><br>Distributed by:<br>Poly Pharmaceuticals, Inc.,<br>Mobile, AL 36619<br><br>Rev. 11/09<br>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-20"></a><p></p>
<h1>PRODUCT PACKAGING:</h1>The packaging below represents the labeling currently used:<br><br><span class="Bold">Principal Display Panel and Side Panel for 473 mL Label:</span><br><br><span class="Bold">NDC 50991-405-16</span><br><br><span class="Bold">POLY HIST</span><br><span class="Bold">PD</span><br><br><span class="Bold">EACH TEASPOONFUL (5 mL)</span><br><span class="Bold">FOR ORAL ADIMISTRATION CONTAINS:</span><br><br><span class="Bold">PYRILAMINE MALEATE..................12.5 mg</span><br><span class="Bold">CHLORPHENIRAMINE MALEATE...... 2 mg</span><br><span class="Bold">PHENYLEPHRINE HCl......................7.5 mg</span><br><br><ul>
<li><span class="Bold">SUGAR FREE</span></li>
<li><span class="Bold">ALCOHOL FREE</span></li>
<li><span class="Bold">DYE FREE</span></li>
</ul>
<span class="Bold">Rx Only</span><br><br><span class="Bold">16 fl oz (473 mL)</span><br><span class="Bold"><br>DOSAGE AND ADMINISTRATION:</span><br><span class="Bold"><span class="Bold">Adults and Children 12 years of age and over:</span> 1-2 teaspoonfuls every 4-6 hours.<br>Children 6 to under 12 years of age:</span> 1/2 teaspoonful every 4-6 hours.<br><span class="Bold">Not recommended for Children under 6 years of age.</span><br><span class="Bold"><br>SEE LABEL FOLDOUT FOR FULL PRESCRIBING INFORMATION.</span><br><br><span class="Bold">KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. <br>IN CASE OF ACCIDENTAL <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">OVERDOSE</span>, SEEK PROFESSIONAL </span><span class="Bold">ASSISTANCE <br>OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.</span><br><br>Store at controlled room temperature, 15<span class="Sup">o</span>-30<span class="Sup">o</span>C (59<span class="Sup">o</span>-86<span class="Sup">o</span>F).<br>Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant closure.<br><br>This bottle is not to be dispensed to consumer.<br><br>Tamper evident by heat seal under cap. Do not use if there is evidence of tampering.<br><br>POLY HIST PD is a product of POLY PHARMACEUTICALS, INC.<br><br>Mfg. by: Great Southern Labroatories, Houston, TX 77099<br>Distributed by: Poly Pharmaceuticals, Inc. Mobile, AL 36619<br>Rev. 11/09<br><div class="Figure"><img alt="Poly Hist PD Packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8728160d-6172-4f4e-b512-46f5d9bca733&amp;name=MM1.jpg"></div>
<br><div class="Figure"><img alt="Poly Hist PD Packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8728160d-6172-4f4e-b512-46f5d9bca733&amp;name=MM2.jpg"></div>
<br><div class="Figure"><img alt="Poly Hist PD Packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8728160d-6172-4f4e-b512-46f5d9bca733&amp;name=MM3.jpg"></div>
<br>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>POLY HIST 		
					PD</strong><br><span class="contentTableReg">pyrilamine maleate, chlorpheniramine maleate, and phenylephrine hydrochloride liquid</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:50991-405</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Pyrilamine Maleate</strong> (Pyrilamine) </td>
<td class="formItem">Pyrilamine Maleate</td>
<td class="formItem">12.5 mg  in 5 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>Chlorpheniramine Maleate</strong> (Chlorpheniramine) </td>
<td class="formItem">Chlorpheniramine Maleate</td>
<td class="formItem">2 mg  in 5 mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Phenylephrine Hydrochloride</strong> (Phenylephrine) </td>
<td class="formItem">Phenylephrine Hydrochloride</td>
<td class="formItem">7.5 mg  in 5 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">    </td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem">BUBBLE GUM</td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:50991-405-16</td>
<td class="formItem">473 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">08/05/2004</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Poly Pharmaceuticals, Inc.
							(198449894)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Great Southern Laboratories (056139553)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Great Southern Laboratories</td>
<td class="formItem"></td>
<td class="formItem">056139553</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 12/2009<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>0b40b3cb-4d80-4b14-863f-30ae972bceb1</div>
<div>Set id: 8728160d-6172-4f4e-b512-46f5d9bca733</div>
<div>Version: 1</div>
<div>Effective Time: 20091217</div>
</div>
</div> <div class="DistributorName">Poly Pharmaceuticals, Inc.</div></p>
</body></html>
